<DOC>
	<DOCNO>NCT02672462</DOCNO>
	<brief_summary>A single center , self-controlled pilot study safety efficacy renal denervation treatment hypertension .</brief_summary>
	<brief_title>Renal Denervation Treatment Hypertension : A Pilot Safety Efficacy Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Ages 18 75 , male female ; Main renal artery , without accessary renal artery , length 20mm ; Patients take antihypertensive drug drug least 2 week , mean SBP ≥150mmHg 180mmHg base least 3 office blood pressure measurement , ASBP≥135mmHg ≤170mmHg base 24 hr blood pressure monitoring ; Agrees take part trial sign write , informed consent . Renal artery abnormality inappropriate procedure ; Pregnant plan become pregnant ; History orthostatic hypotension ; Type I diabetes ; Estimated GFR &lt; 40mL/min/1.73m2 ; Only one kidney prior kidney transplantation ; Bleeding tendency coagulation related disease ; Acute severe systemic infection ; Prior renal artery interventional procedure prior RDN treatment ; History stroke TIA ; Malignant tumor endstage illnesses ; Secondary hypertension ; Acute coronary event within 2 week ; Other condition deem unsuitable procedure , opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>